Summation Bio

Summation Bio is a gene therapy company that has developed a novel non-viral gene transfer technology. It aims to address the unmet need for delivering large-sized DNA and RNA to various cell types. The company's micronucleus technology enables efficient, standardized, and safe delivery, gene editing, antibody delivery, targeted tumor therapy, and tissue regeneration, allowing healthcare professionals to demonstrate that its innovative gene therapies can treat complex genetic and acquired diseases.